Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
TEVA PHARMA
Dec-13
PLETHICO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2543,479-   
Low Rs313,022-   
Sales per share (Unadj.) Rs604.61,996.4-  
Earnings per share (Unadj.) Rs32.5124.7-  
Cash flow per share (Unadj.) Rs51.3286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs473.72,217.6-  
Shares outstanding (eoy) m34.07848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.21.6 14.5%   
Avg P/E ratio x4.426.1 16.8%  
P/CF ratio (eoy) x2.811.4 24.5%  
Price / Book Value ratio x0.31.5 20.5%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m4,8592,756,220 0.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,5470-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m20,5981,692,969 1.2%  
Other income Rs m4190-   
Total revenues Rs m21,0171,692,969 1.2%   
Gross profit Rs m2,938463,620 0.6%  
Depreciation Rs m642136,844 0.5%   
Interest Rs m1,74733,253 5.3%   
Profit before tax Rs m968293,523 0.3%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m-138-3,584 3.9%   
Profit after tax Rs m1,107105,758 1.0%  
Gross profit margin %14.327.4 52.1%  
Effective tax rate %-14.3-1.2 1,170.4%   
Net profit margin %5.46.2 86.0%  
BALANCE SHEET DATA
Current assets Rs m18,8771,143,425 1.7%   
Current liabilities Rs m11,896997,163 1.2%   
Net working cap to sales %33.98.6 392.3%  
Current ratio x1.61.1 138.4%  
Inventory Days Days7891 86.0%  
Debtors Days Days19896 206.3%  
Net fixed assets Rs m14,269552,961 2.6%   
Share capital Rs m3414,167 8.2%   
"Free" reserves Rs m15,7980-   
Net worth Rs m16,1391,880,567 0.9%   
Long term debt Rs m4,706865,653 0.5%   
Total assets Rs m33,1463,868,976 0.9%  
Interest coverage x1.69.8 15.8%   
Debt to equity ratio x0.30.5 63.3%  
Sales to assets ratio x0.60.4 142.0%   
Return on assets %8.63.6 239.6%  
Return on equity %6.95.6 122.0%  
Return on capital %13.04.9 264.1%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,437269,772 0.9%  
From Investments Rs m-6,265-95,591 6.6%  
From Financial Activity Rs m2,490-323,609 -0.8%  
Net Cashflow Rs m24-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare PLETHICO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PLETHICO PHARMA With: RPG LIFE SCIENCES  LYKA LABS  GUJ.TERC LAB  OMKAR PHARMACHEM  S.S.ORGANICS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.